View Future GrowthWaters 過去の業績過去 基準チェック /36Watersの収益は年間平均-0.3%の割合で減少していますが、 Life Sciences業界の収益は年間 増加しています。収益は年間5.3% 3.4%割合で 増加しています。 Watersの自己資本利益率は25.1%であり、純利益率は20.3%です。主要情報-0.29%収益成長率0.72%EPS成長率Life Sciences 業界の成長12.91%収益成長率3.45%株主資本利益率25.09%ネット・マージン20.30%次回の業績アップデート05 May 2026最近の業績更新Full year 2025 earnings released: EPS: US$10.80 (vs US$10.75 in FY 2024) Feb 10Waters Corporation to Report Q4, 2025 Results on Feb 09, 2026Jan 27Third quarter 2025 earnings released: EPS: US$2.50 (vs US$2.72 in 3Q 2024) Nov 05Waters Corporation to Report Q3, 2025 Results on Nov 04, 2025Oct 01Second quarter 2025 earnings released: EPS: US$2.47 (vs US$2.41 in 2Q 2024) Aug 05Full year 2024 earnings released: EPS: US$10.75 (vs US$10.87 in FY 2023) Feb 14すべての更新を表示Recent updatesWaters Corporation Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC Powering Rapid Characterization of Large MoleculesApr 15Waters Corporation, Annual General Meeting, May 21, 2026Apr 10Waters Corporation Announces U.S. Food and Drug Administration Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV AssayApr 08Independent Director recently bought Mex$2.6m worth of stock Mar 20Independent Director recently bought Mex$5.4m worth of stock Mar 14Waters Corporation Launches ARES-G3 RheometerMar 10Investor sentiment deteriorates as stock falls 18% Feb 16New major risk - Shareholder dilution Feb 14Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 4, 2026 and Full Year Ending December 31, 2026Feb 10Full year 2025 earnings released: EPS: US$10.80 (vs US$10.75 in FY 2024) Feb 10Waters Corporation (NYSE:WAT) completed the acquisition of Biosciences and Diagnostics Solutions Business of Becton, Dickinson and Company (NYSE:BDX) in a transaction valued at $18.8 billion.Feb 10Waters Corporation Appoints Claire M. Fraser to Its Board of DirectorsFeb 09Waters Corporation to Report Q4, 2025 Results on Feb 09, 2026Jan 27Waters Corporation Boosts Lab Productivity and Sample Throughput with Launch of Its Charged Aerosol Detector Designed for Empower SoftwareNov 12Third quarter 2025 earnings released: EPS: US$2.50 (vs US$2.72 in 3Q 2024) Nov 05Waters Corporation Raises Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2025Nov 05Waters Corporation to Report Q3, 2025 Results on Nov 04, 2025Oct 01Now 21% undervalued after recent price drop Sep 26Second quarter 2025 earnings released: EPS: US$2.47 (vs US$2.41 in 2Q 2024) Aug 05Waters Corporation Raises Earnings Guidance for the Full Year 2025Aug 04+ 1 more updateInvestor sentiment deteriorates as stock falls 15% Jul 17Waters Corporation (NYSE:WAT) entered into a definitive agreement to acquire Biosciences and Diagnostics Solutions Business of Becton Dickinson and Company in a transaction valued at $17.5 billion.Jul 15Now 21% undervalued after recent price drop Jul 15Waters Corporation (NYSE:WAT) acquired Halo Labs.May 23Waters Corporation (NYSE:WAT) acquired Optofluidics, Inc.May 21Waters Corporation Provides Earnings Guidance for the Second Quarter Ending June 28, 2025 and Full Year Ending December 31, 2025May 06Waters Corporation, Annual General Meeting, May 22, 2025Apr 11Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QCApr 01Full year 2024 earnings released: EPS: US$10.75 (vs US$10.87 in FY 2023) Feb 14Full year 2024 earnings released: EPS: US$10.75 (vs US$10.87 in FY 2023) Feb 13Waters Corporation Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025Feb 13Investor sentiment improves as stock rises 17% Nov 09Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024Nov 02Third quarter 2024 earnings released: EPS: US$2.72 (vs US$2.28 in 3Q 2023) Nov 01Waters Corporation Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2024Nov 01Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS AnalysisOct 14Waters Corporation Introduces TA Instruments Discovery Core RheometerOct 08Second quarter 2024 earnings released: EPS: US$2.41 (vs US$2.56 in 2Q 2023) Aug 01Waters Corporation to Report Q2, 2024 Results on Jul 31, 2024Jul 31+ 1 more updateWaters Corporation New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody DrugsJul 23Independent Director recently bought Mex$5.6m worth of stock May 31First quarter 2024 earnings released: EPS: US$1.73 (vs US$2.39 in 1Q 2023) May 08Waters Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024May 08Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC ColumnsApr 23Waters Corporation, Annual General Meeting, May 23, 2024Mar 30Independent Director recently sold Mex$3.0m worth of stock Mar 16Full year 2023 earnings released: EPS: US$10.87 (vs US$11.80 in FY 2022) Feb 08Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024Feb 06High number of new directors Jan 18Third quarter 2023 earnings released: EPS: US$2.28 (vs US$2.61 in 3Q 2022) Nov 09High number of new directors Nov 06Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters DivisionOct 25Waters Corporation Launched OligoWorks SPE Workflow and KitsOct 20High number of new directors Oct 18Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle AnalysisSep 21Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023Aug 04Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy ApplicationsAug 02High number of new directors Jul 17Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS ImagingJun 06+ 1 more updateWaters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023May 10High number of new directors Apr 04High number of new directors Mar 15Independent Director recently bought Mex$18m worth of stock Mar 02High number of new directors Feb 21Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023Feb 16High number of new directors Jan 31Waters Corporation Announces Waters_Connect™ System MonitoringJan 26Second quarter 2022 earnings released: EPS: US$2.74 (vs US$2.71 in 2Q 2021) Aug 03Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 27High number of new directors Dec 01Third quarter 2021 earnings released: EPS US$2.63 (vs US$2.05 in 3Q 2020) Nov 05High number of new directors Nov 05Independent Director Michael Berendt has left the company Oct 12Independent Director recently sold Mex$24m worth of stock Aug 26High number of new directors Aug 26Investor sentiment improved over the past week Aug 11Lead Independent Director recently sold Mex$67m worth of stock Aug 08Second quarter 2021 earnings released: EPS US$2.71 (vs US$1.99 in 2Q 2020) Aug 05High number of new directors Aug 05First quarter 2021 earnings released: EPS US$2.38 (vs US$0.86 in 1Q 2020) May 07収支内訳Waters の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BMV:WAT * 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費31 Dec 253,16564374519627 Sep 253,10664972319628 Jun 253,04666170518729 Mar 252,98365769118531 Dec 242,95863867318328 Sep 242,90562367918029 Jun 242,87759666917730 Mar 242,90960467117731 Dec 232,95664269117530 Sep 232,99565369017901 Jul 232,99267569618001 Apr 232,96668968217831 Dec 222,97270865817601 Oct 222,95069765817102 Jul 222,90170264517002 Apr 222,86870564117131 Dec 212,78669362716802 Oct 212,73669560616503 Jul 212,67166056315803 Apr 212,50961654114431 Dec 202,36552255514126 Sep 202,29550450713827 Jun 202,27851552413828 Mar 202,35853752214331 Dec 192,40759252614328 Sep 192,40557758214429 Jun 192,40658058414530 Mar 192,40359158914431 Dec 182,42059458514329 Sep 182,3925554314030 Jun 182,3805155013931 Mar 182,3422754013631 Dec 172,3092054513330 Sep 172,25154851213001 Jul 172,21253750112701 Apr 172,19053350212731 Dec 162,16752251212501 Oct 162,12549850812102 Jul 162,09949050912102 Apr 162,05746750211931 Dec 152,04246949311903 Oct 152,04046949811904 Jul 152,032467496116質の高い収益: WAT *は 高品質の収益 を持っています。利益率の向上: WAT *の現在の純利益率 (20.3%)は、昨年(21.6%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: WAT *の収益は過去 5 年間で年間0.3%減少しました。成長の加速: WAT *の過去 1 年間の収益成長率 ( 0.8% ) は、5 年間の平均 ( 年間-0.3%を上回っています。収益対業界: WAT *の過去 1 年間の収益成長率 ( 0.8% ) Life Sciences業界11.1%を上回りませんでした。株主資本利益率高いROE: WAT *の 自己資本利益率 ( 25.1% ) は 高い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/04/30 23:07終値2026/04/28 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Waters Corporation 21 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。39 アナリスト機関Catherine Ramsey SchulteBairdCharles ButlerBarclaysLuke SergottBarclays36 その他のアナリストを表示
Waters Corporation Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC Powering Rapid Characterization of Large MoleculesApr 15
Waters Corporation Announces U.S. Food and Drug Administration Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV AssayApr 08
Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 4, 2026 and Full Year Ending December 31, 2026Feb 10
Waters Corporation (NYSE:WAT) completed the acquisition of Biosciences and Diagnostics Solutions Business of Becton, Dickinson and Company (NYSE:BDX) in a transaction valued at $18.8 billion.Feb 10
Waters Corporation Boosts Lab Productivity and Sample Throughput with Launch of Its Charged Aerosol Detector Designed for Empower SoftwareNov 12
Waters Corporation Raises Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2025Nov 05
Waters Corporation (NYSE:WAT) entered into a definitive agreement to acquire Biosciences and Diagnostics Solutions Business of Becton Dickinson and Company in a transaction valued at $17.5 billion.Jul 15
Waters Corporation Provides Earnings Guidance for the Second Quarter Ending June 28, 2025 and Full Year Ending December 31, 2025May 06
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QCApr 01
Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024Nov 02
Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS AnalysisOct 14
Waters Corporation New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody DrugsJul 23
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC ColumnsApr 23
Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters DivisionOct 25
Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle AnalysisSep 21
Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS ImagingJun 06+ 1 more update
Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023May 10
Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023Feb 16